Diabetes market grows ever more crowded.
P & T : a Peer-Reviewed Journal for Formulary Management
|December 18, 2014
Summary
Type-2 diabetes is a growing global health concern, with millions affected and billions spent on medications. The current market faces challenges with generic drugs and limited innovation in new treatments.
Area of Science:
- Endocrinology
- Pharmacology
- Public Health
Background:
- Global type-2 diabetes prevalence is rising, projected to affect 330 million individuals by 2022.
- The pharmaceutical market for diabetes medications is substantial, estimated at $67.7 billion.
- Current market saturation includes numerous generic options, limiting therapeutic diversity.
Purpose of the Study:
- To analyze the current landscape of type-2 diabetes medications.
- To identify trends in drug development within the type-2 diabetes market.
- To assess the impact of generic competition and "me-too" drugs on therapeutic innovation.
Main Methods:
- Market analysis of global diabetes medication sales.
- Review of pharmaceutical development pipelines for type-2 diabetes treatments.
- Assessment of drug classes and competitive positioning.
Main Results:
- The type-2 diabetes medication market is characterized by a high volume of generic drugs.
- A significant portion of drugs in development are classified as "me-too" compounds, offering marginal improvements.
- Limited novel therapeutic agents are emerging, suggesting a potential stagnation in innovation.
Conclusions:
- The type-2 diabetes drug market is highly competitive and dominated by generics.
- The pipeline lacks truly novel therapies, with a prevalence of incremental innovations.
- Addressing the growing burden of type-2 diabetes may require a shift towards more innovative therapeutic strategies.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
01:26Diabetes Mellitus: Introduction
2
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
2
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Overview and Type I Subtype
6.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.5K
01:20Pathophysiology of Diabetes
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.7K
01:26Type I Diabetes II: Pathophysiology
6
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
6